Single-cell sequencing to quantify genomic integrity in cancer

van den Bos, H., Bakker, B., Spierings, D. C. J., Lansdorp, P. M. & Foijer, F., Jan-2018, In : International journal of biochemistry & cell biology. 94, p. 146-150 5 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Copy link to clipboard


  • Single-cell sequencing to quantify genomic integrity in cancer

    Final publisher's version, 243 KB, PDF document


The use of single-cell DNA sequencing (sc-seq) techniques for the diagnosis, prognosis and treatment of cancer is a rapidly developing field. Sc-seq research is gaining momentum by decreased sequencing costs and continuous improvements in techniques. In this review, we provide an overview of recent advancements in the field of sc-seq in cancer and we discuss how sc-seq can contribute to improved care for cancer patients. Sc-seq has made it possible to study the genomes of individual cancer cells from primary tumors, metastases and circulating tumor cells, revealing inter- and intra-tumor heterogeneity, which cannot be detected using other methods. We review studies on individual human cancer cells in relation to prognosis and treatment response. Finally, future perspectives of sc-seq in cancer diagnosis and treatment are discussed with a focus on the use of circulating tumor cells to monitor therapy response and the development of personalized treatments based on knowledge about the genomic heterogeneity.

Original languageEnglish
Pages (from-to)146-150
Number of pages5
JournalInternational journal of biochemistry & cell biology
Early online date23-Sep-2017
Publication statusPublished - Jan-2018


  • Single-cell sequencing, Intra-tumor heterogeneity, Tumor evolution, Circulating tumor cells, CIRCULATING TUMOR-CELLS, BREAST-CANCER, LUNG-CANCER, EVOLUTION, NUCLEOTIDE, ANEUPLOIDY, ORIGIN

ID: 48487881